Can a targeted procedure ease the burden of desmoid tumors?

NCT ID NCT07755176

ENROLLING_BY_INVITATION Symptom relief Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study asks whether a procedure called percutaneous ablation can reduce symptoms and improve daily life for adults with desmoid tumors. Participants will complete surveys before and after the procedure to track symptom severity, pain, recovery, and how the tumor responds on imaging. The goal is to better understand the real-world impact of this treatment from the patient's perspective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: percutaneous ablation (a procedure using heat or cold to destroy the tumor)
What this could lead to: If successful, this could help doctors understand whether ablation improves symptoms and quality of life for people with desmoid tumors.
What could go wrong: This is a small, early-stage study focused on patient-reported outcomes, not a direct comparison of treatments. Results may not apply to all patients, and ablation carries risks like pain or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGGRESSIVE FIBROMATOSES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

desmoid tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGGRESSIVE FIBROMATOSES DESMOID TUMOR

Contacts and locations

Locations

Mayo Clinic

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.